News Releases

February 13, 2020
Urovant Sciences Reports 2019 Third Fiscal Quarter Financial Results
IRVINE, Calif. & BASEL, Switzerland --(BUSINESS WIRE)--Feb. 13, 2020-- Urovant Sciences (Nasdaq: UROV) today reported financial results for the 2019 third fiscal quarter ended December 31, 2019 . Recent Business Highlights Submitted a New Drug Application for vibegron for the treatment of patients
Additional Formats
January 17, 2020
Urovant Sciences to Ring the Nasdaq Stock Market Opening Bell
IRVINE, Calif. & BASEL, Switzerland --(BUSINESS WIRE)--Jan. 17, 2020-- Urovant Sciences (Nasdaq: UROV) announced today that Chief Executive Officer Keith Katkin and other Urovant executives will ring the opening bell of the Nasdaq Stock Market on Tuesday, January 21, 2020 , at 9:30 a.m. Eastern.
Additional Formats
Displaying 11 - 19 of 19